BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3495732)

  • 1. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis.
    Hughes WT; Rivera GK; Schell MJ; Thornton D; Lott L
    N Engl J Med; 1987 Jun; 316(26):1627-32. PubMed ID: 3495732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.
    Hughes WT; Kuhn S; Chaudhary S; Feldman S; Verzosa M; Aur RJ; Pratt C; George SL
    N Engl J Med; 1977 Dec; 297(26):1419-26. PubMed ID: 412099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
    Lindemulder S; Albano E
    Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infection prophylaxis in patients with hematological malignancies (I)--Successful prophylaxis of Pneumocystis carinii pneumonitis with sulfamethoxazole-trimethoprim].
    Moriuchi Y; Kamihira S; Satoh T; Yanagisako T; Miyazaki Y; Nagai K; Murata K; Tokunaga S; Maeda T; Atogami S
    Rinsho Ketsueki; 1990 Nov; 31(11):1818-22. PubMed ID: 2287067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
    Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
    Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group.
    Siegel SE; Wolff LJ; Baehner RL; Hammond D
    Am J Dis Child; 1984 Nov; 138(11):1051-4. PubMed ID: 6388315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
    White MV; Haddad ZH; Brunner E; Sainz C
    Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
    Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia.
    Hughes WT; Smith BL
    Antimicrob Agents Chemother; 1983 Aug; 24(2):300-1. PubMed ID: 6605717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
    Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
    N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects of trimethoprim-sulfamethoxazole in patients with AIDS].
    Weinke T; Sixt C; de Matos-Marques B; Ruf B; Pohle HD
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1129-33. PubMed ID: 3260553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole.
    Hughes WT; Feldman S; Sanyal SK
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):47-50. PubMed ID: 1079469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
    Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
    Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
    Martin MA; Cox PH; Beck K; Styer CM; Beall GN
    Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.
    Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB
    Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.